Procter & Gamble Health Limited (NSE:PGHL) — Market Cap & Net Worth

$936.52 Million USD · Rs86.60 Billion INR · Rank #9388

Market Cap & Net Worth: Procter & Gamble Health Limited (PGHL)

Procter & Gamble Health Limited (NSE:PGHL) has a market capitalization of $936.52 Million (Rs86.60 Billion) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #9388 globally and #443 in its home market, demonstrating a 1.64% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Procter & Gamble Health Limited's stock price Rs5216.90 by its total outstanding shares 16599382 (16.60 Million). Analyse cash flow conversion of Procter & Gamble Health Limited to see how efficiently the company converts income to cash.

Procter & Gamble Health Limited Market Cap History: 2015 to 2026

Procter & Gamble Health Limited's market capitalization history from 2015 to 2026. Data shows growth from $111.38 Million to $936.52 Million (22.06% CAGR).

Index Memberships

Procter & Gamble Health Limited is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.11 Trillion	0.08%	#249 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.03%	#368 of 750

Weight: Procter & Gamble Health Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Procter & Gamble Health Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Procter & Gamble Health Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.08x

Procter & Gamble Health Limited's market cap is 0.08 times its annual revenue

Industry average: 1.04x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.37x

Procter & Gamble Health Limited's market cap is 0.37 times its annual earnings

Industry average: 8.30x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$144.92 Million	$9.93 Billion	$791.30 Million	0.01x	0.18x
2017	$191.04 Million	$6.98 Billion	$939.10 Million	0.03x	0.20x
2018	$459.47 Million	$8.49 Billion	$8.39 Billion	0.05x	0.05x
2019	$719.69 Million	$8.89 Billion	$1.66 Billion	0.08x	0.43x
2020	$1.13 Billion	$10.09 Billion	$1.77 Billion	0.11x	0.64x
2020	$1.13 Billion	$11.55 Billion	$2.05 Billion	0.10x	0.55x
2021	$900.80 Million	$11.14 Billion	$1.93 Billion	0.08x	0.47x
2022	$675.17 Million	$12.30 Billion	$2.29 Billion	0.05x	0.29x
2023	$869.99 Million	$11.51 Billion	$2.01 Billion	0.08x	0.43x
2024	$940.31 Million	$12.18 Billion	$2.51 Billion	0.08x	0.37x

Competitor Companies of PGHL by Market Capitalization

Companies near Procter & Gamble Health Limited in the global market cap rankings as of May 4, 2026.

Key companies related to Procter & Gamble Health Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#499	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#525	Zoetis Inc	NYSE:ZTS	$50.31 Billion	$114.16
#526	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$50.29 Billion	CN¥53.88
#572	GALDERMA GROUP AG	NYSE:GALDY	$45.88 Billion	$42.15

Procter & Gamble Health Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Procter & Gamble Health Limited's market cap moved from $111.38 Million to $ 936.52 Million, with a yearly change of 22.06%.

Year	Market Cap	Change (%)
2026	Rs936.52 Million	-8.52%
2025	Rs1.02 Billion	+8.88%
2024	Rs940.31 Million	+8.08%
2023	Rs869.99 Million	+28.86%
2022	Rs675.17 Million	-25.05%
2021	Rs900.80 Million	-20.39%
2020	Rs1.13 Billion	+57.23%
2019	Rs719.69 Million	+56.63%
2018	Rs459.47 Million	+140.52%
2017	Rs191.04 Million	+31.82%
2016	Rs144.92 Million	+30.11%
2015	Rs111.38 Million	--

End of Day Market Cap According to Different Sources

On May 4th, 2026 the market cap of Procter & Gamble Health Limited was reported to be:

Source	Market Cap
Yahoo Finance	$936.52 Million USD
MoneyControl	$936.52 Million USD
MarketWatch	$936.52 Million USD
marketcap.company	$936.52 Million USD
Reuters	$936.52 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic

Market Cap

$936.52 Million

Rs86.60 Billion INR

Market Cap Rank

#9388 Global

#443 in India

Share Price

Rs5216.90

Change (1 day)

+1.59%

52-Week Range

Rs4778.60 - Rs6581.50

All Time High

Rs6870.36